In vivo and in silico study demonstrates enhanced antifungal activity of 4-bromothymol against resistant fungi, indicating membrane disruption drives fungicidal action.
Monoterpenoids are well-recognized natural antimycotic agents, but their mechanism of action is still unclear. Interestingly, synthetic derivatives, such as 4-bromothymol (4-bromo-2-isopropyl-5-methylphenol), are emerging as promising alternatives to natural molecules, due to their even greater biological activity. Herein, the antimycotic efficacy of 4-bromothymol is evaluated: in vivo experiments on species of acclaimed resistance demonstrate that 4-bromothymol has a minimum inhibitory concentration up to 6 times lower than thymol. In silico investigations, sweeping from partition coefficient (LogP) determination through density functional theory and molecular dynamics simulations based on a minimum bias approach, support its improved antifungal activity with respect to thymol, carvacrol, and thymyl acetate. A structural insight of the mechanism of action is proposed. Even though all the analyzed compounds are able to penetrate the cellular membrane, 4-bromothymol shows a higher predicted affinity for the bilayer, and it causes a strong perturbation at the water/bilayer interface, altering the stability of the membrane, thus leading to cell death.
No takes yet. Share an insight, caveat, or question.
Pezzola et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: